According to MarketsandMarkets™, The report ” Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) – Global Forecast to 2030″, is anticipated to reach USD 8.18 billion in 2030 from USD 5.34 billion in 2025, with a significant CAGR of 8.9%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059
Browse
- 552 Market Data Tables
- 47 Figures
- 414 Pages and in-depth TOC on “ Clinical Trial Supplies Market – Global Forecast to 2030”.
Some of the prominent key players are:
- Almac Group (UK),
- Novo Holdings A/S (Denmark),
- Marken (UPS) (US),
- PCI Pharma Services (US),
- Sharp Services LLC (US),
- Thermo Fisher Scientific Inc. (US), and many more……
Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Clinical Trial Supplies Market.
Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059
- The services segment is sub-segmented into Logistics & distribution services, storage & retention services, packaging, labeling and blinding services, manufacturing services, comparator sourcing services and other services. The logistics & distribution services segmented dominated the market.
- The phase segment is divided into phase I, Phase II, Phase III, Phase IV and Phase BA/BE. The Phase III segment dominated the Clinical Trial Supplies Market in 2024 due to its critical role in the drug development process, requiring large-scale patient recruitment and extensive supply chain management. The Phase II segment is anticipated to grow at a significant CAGR during the forecast period
- The therapeutic area segment is further divided into oncology, neurology, respiratory disorder, metabolic disorder/endocrinology, cardiovascular system disorders, dermatology, gastrointestinal, immunological disorder, infectious diseases, psychiatry, ophthalmology, haematology, genitourinary and women’s health, and others.
- Based on the end users, the market is segmented into pharmaceutical & biotechnology companies, CROs & CDMOs and Other end users. Pharmaceutical & biotechnology companies dominated the segment in 2024 and is anticipated to grow at the highest significant CAGR during the forecast period of 2025-2030.
- The Clinical Trial Supplies market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2024, North America dominated the Clinical Trial Supplies Market due to its strong pharmaceutical and biotechnology industry, high R&D investments, and well-established clinical trial infrastructure.
The clinical trial supplies market is skyrocketing due to various factors such as the adoption of digital solutions, AI, and blockchain for tracking and optimizing supply distribution, increasing demand for specialized storage and transportation solutions, and growing use of comparators in head-to-head studies. Furthermore, higher R&D spending by pharma and biotech companies and government and private funding initiatives supporting drug development is further propelling the market growth.
Related Reports:
Contract Research Organization Services Market – Global Forecast to 2030
Clinical Trial Imaging Market – Global Forecast to 2029
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Global Clinical Trial Supplies Market Projected to Hit $8.18 Billion by 2030
